Johnson & Johnson
JNJ
$151.22
Share price
0.87%
Change (1 day)
-5.22%
Change (1 year)
Categories
Johnson & Johnson is a global American pharmaceutical and consumer goods company with headquarters in New Brunswick, New Jersey. The company is listed in the Dow Jones Industrial Average.
Johnson & Johnson (JNJ) - Total debt
Total debt on the balance sheet as of March 2024 : $33.63 B
According to Johnson & Johnson's latest financial reports the company's total debt is $33.63 B. A company’s total debt is the sum of all current and non-current debts.
Johnson & Johnson - Total debt on balance sheet (from 2001 to 2024)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023-12-31 | $29.33 B | -26.01% |
| 2022-12-31 | $39.64 B | 17.45% |
| 2021-12-31 | $33.75 B | -4.3% |
| 2020-12-31 | $35.26 B | 27.33% |
| 2019-12-31 | $27.69 B | -9.13% |
| 2018-12-31 | $30.48 B | -11.86% |
| 2017-12-31 | $34.58 B | 27.48% |
| 2016-12-31 | $27.12 B | 36.58% |
| 2015-12-31 | $19.86 B | 5.87% |
| 2014-12-31 | $18.76 B | 3.19% |
| 2013-12-31 | $18.18 B | 12.47% |
| 2012-12-31 | $16.16 B | -17.64% |
| 2011-12-31 | $19.62 B | 17.02% |
| 2010-12-31 | $16.77 B | 15.35% |
| 2009-12-31 | $14.54 B | 22.69% |
| 2008-12-31 | $11.85 B | 24.27% |
| 2007-12-31 | $9.53 B | 44.65% |
| 2006-12-31 | $6.59 B | 145.55% |
| 2005-12-31 | $2.68 B | -5.62% |
| 2004-12-31 | $2.84 B | -30.51% |
| 2003-12-31 | $4.09 B | -1.09% |
| 2002-12-31 | $4.13 B | 48.78% |
| 2001-12-31 | $2.78 B |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Novartis NVS | $27.28 B | -18.87% | 🇨🇭 Switzerland |
 Pfizer PFE | $70.84 B | 110.65% | 🇺🇸 USA |
 Abbott Laboratories ABT | $15.62 B | -53.53% | 🇺🇸 USA |
 Medtronic MDT | $25.18 B | -25.12% | 🇮🇪 Ireland |
 Eli Lilly LLY | $26.21 B | -22.06% | 🇺🇸 USA |
 Sanofi SNY | $20.36 B | -39.44% | 🇫🇷 France |
 Gilead Sciences GILD | $24.98 B | -25.70% | 🇺🇸 USA |
 Stryker Corporation SYK | $12.86 B | -61.75% | 🇺🇸 USA |
 Merck MRK | $35.05 B | 4.23% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $22.45 B | -33.22% | 🇬🇧 UK |